LETROZOL TEVA PHARMA 2,5 MG TBL FLM 30
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, zkontrolujte ale specializaci předepisujícího lékaře níže (tzv. nedelegovatelná preskripce). Maximální doplatek: 1 996,77 Kč. Maximální cena: 2 220,01 Kč. |
| Kdo může předepsat | clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology |
| Složení | Letrozol (2,5 mg), mikrokrystalická celulosa, kukuřičný škrob, magnesium-stearát, monohydrát laktosy, koloidní bezvodý oxid křemičitý, sodná sůl karboxymethylškrobu (typ a), potahová soustava opadry ii 85f32723 žlutá. D… |
| Dostupnost / výpadek | Výpadek The latest report from the manufacturer is from 2. 12. 2025. Výroba byla přerušena od 22. 12. 2025. The stated reason was: Výrobní důvody. Resumption of supply is expected 30. 9. 2026Výrobce jako potenciální náhradu uvádí léky s k… |
| Kód SÚKL | 0199473 |
What is the maximum co-payment for LETROZOL TEVA PHARMA?
If the insurance company contributes, the maximum co-payment is 1 996,77 Kč. The maximum pharmacy price is 2 220,01 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).
Does LETROZOL TEVA PHARMA have a counted co-payment set?
Yes, the medicine has a counted co-payment of 337,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
223,24 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe LETROZOL TEVA PHARMA?
- clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
What is the composition of LETROZOL TEVA PHARMA?
Letrozol (2,5 mg), mikrokrystalická celulosa, kukuřičný škrob, magnesium-stearát, monohydrát laktosy, koloidní bezvodý oxid křemičitý, sodná sůl karboxymethylškrobu (typ a), potahová soustava opadry ii 85f32723 žlutá. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to LETROZOL TEVA PHARMA?
The medicine belongs to ATC group L02BG04 – Letrozol. Medicines with the same active substance can be found here.
Who manufactures LETROZOL TEVA PHARMA?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 2. 12. 2025. Production was interrupted as of 22. 12. 2025. The stated reason was: Výrobní důvody.
Resumption of supply is expected 30. 9. 2026
The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for LETROZOL TEVA PHARMA?
The medicine has code 0199473. Code details can be found here.
How many packs of LETROZOL TEVA PHARMA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of LETROZOL TEVA PHARMA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026